From: The role of the fat mass and obesity associated gene (FTO) in breast cancer risk
 | Cases N = 354 n (%) | Controls N = 364 n (%) | p-value |
---|---|---|---|
Age (yr): median (range) | 50 (24-83) | 47 (19-87) | 0.60 |
Race | Â | Â | Â |
   Caucasian | 250 (72.5) | 263 (72.3) | - |
   Black | 56 (16.2) | 59 (16.3) | 0.99 |
   Asian | 19 (5.5) | 26 (7.1) | 0.34 |
   Hispanic | 13 (3.8) | 9 (2.7) | 0.40 |
   Other | 7 (2.0) | 6 (1.6) | 0.71 |
Weight (lbs): median (range) | 155 (96-317) | 157 (93-435) | 0.03 |
Height (in): median (range) | 65 (59-71) | 65 (52-73) | 0.66 |
BMI (kg/m 2 ): median (range) | 26.07 (17.61-51.43) | 26.07 (16.91-79.61) | 0.04 |
Tumor grade | Â | Â | Â |
   1 | 52 (14.7) |  |  |
   2 | 132 (37.3) |  |  |
   3 | 118 (33.3) |  |  |
Stage at diagnosis | Â | Â | - |
   I | 106 (31.4) |  |  |
   II | 140 (41.4) |  |  |
   III/IV | 92 (27.2) |  |  |
ER status | Â | Â | - |
   + | 270 (78.9) |  |  |
   - | 72 (21.1) |  |  |
PR status | Â | Â | - |
   + | 238 (70.8) |  |  |
   - | 98 (29.2) |  |  |
Her2 status | Â | Â | - |
   + | 58 (18.0) |  |  |
   - | 264 (82.0) |  |  |
LN status | Â | Â | - |
   + | 176 (53.8) |  |  |
   - | 151 (46.2) |  |  |
Family history | Â | Â | - |
   + | 138 (48.1) |  |  |
   - | 149 (51.9) |  |  |
Median follow-up (mo) | 29 | Â | - |